Abstract-ATP-sensitive K ϩ (K ATP ) channels are broadly distributed in the vasculature and regulate arterial tone. These channels are inhibited by intracellular ATP ([ATP] i ) and vasoconstrictor agents and can be activated by vasodilators. It is widely assumed that K ATP channels are insensitive to Ca 2ϩ , although regulation has not been examined in the intact cell where cytosolic regulatory processes may be important. Thus we investigated the effects of Ca 2ϩ on whole-cell K ATP current in rat aortic smooth muscle cells recorded in a physiological [ATP] i and K ϩ gradient. Under control recording conditions, cells had a resting potential of ϷϪ40 mV when bathed in 1.8 mmol/L Ca 2ϩ . The K ATP channel inhibitor glibenclamide caused membrane depolarization (9 mV) and inhibited a small, time-independent background current. Reducing [ATP] i from 3 to 0.1 mmol/L hyperpolarized cells to ϷϪ60 mV and increased glibenclamide-sensitive current by 2-to 4-fold. Similar effects were observed when Ca 2ϩ levels were decreased either externally or internally by increasing EGTA from 1 to 10 mmol/L. Dialysis with solutions containing different free [Ca 2ϩ ] i showed that K ATP current was maximally activated at 10 nmol/L [Ca 2ϩ ] i and almost totally inhibited at 300 nmol/L. Moreover, under control conditions, when rat aortic smooth muscle cells were dialyzed with either cyclosporin A, FK-506, or calcineurin autoinhibitory peptide (structurally unrelated inhibitors of Ca 2ϩ -dependent protein phosphatase, type 2B), glibenclamide-sensitive currents were large and the resting potential was hyperpolarized by Ϸ20 to 25 mV. We report for the first time that K ATP channels can be modulated by Ca 2ϩ at physiological [ATP] i and conclude that modulation occurs via protein phosphatase type 2B.
P
otassium channels inhibited by intracellular adenosine-5Ј-triphosphate (K ATP ) and glibenclamide have been identified in many different cell types. In vascular smooth muscle, opening of these channels causes K ϩ efflux and membrane hyperpolarization leading to the closure of voltage-gated Ca 2ϩ channels and, hence, vasorelaxation. 1 There is convincing evidence that K ATP channels are the target for several endogenous vasoconstrictors (eg, angiotensin II) and vasodilators (eg, calcitonin gene-related peptide), [1] [2] [3] all of which are capable of modulating intracellular Ca 2ϩ levels ([Ca 2ϩ ] i ). Vascular K ATP channels are inhibited at a half-maximal concentration of intracellular ATP ([ATP] i ) of between 10 and 300 mol/L, 1 and because [ATP] i in arterial smooth muscle is on the order of 1.5 to 3 mmol/L, 4 it is anticipated that these channels would normally be closed under physiological conditions. However, several reports show that glibenclamide depolarizes intact blood vessels 5, 6 or isolated cells in the perforated patch configuration 7 in vitro and decreases resting blood flow in vivo. 8 These observations suggest that K ATP channels are open and do indeed contribute to the resting membrane potential and maintenance of arterial tone in some smooth muscles. 1 Moreover, other factors, including various protein kinases, are known to regulate the activity of these channels presumably by controlling the degree of phosphorylation of the channel itself or a closely associated protein. 1, 9 Classically, K ATP channels have been investigated under conditions where [Ca 2ϩ ] i is buffered to low levels and external Ca 2ϩ ([Ca 2ϩ ] o ) has been removed. Such conditions have been used primarily because several single-channel studies 1 have indicated that K ATP channels are insensitive to Ca 2ϩ but also to minimize the activity of Ca 2ϩ -dependent K ϩ and chloride channels. To our knowledge, there has been only one report to date of Ca 2ϩ modulation of K ATP channels in freshly isolated smooth muscle cells, where a small conductance channel activated by micromolar [Ca 2ϩ ] i and inhibited by [ATP] i was observed in excised patches in rat portal vein. 10 In cultured porcine coronary myocytes, K ATP channels with a high activity at a physiological [Ca 2ϩ ] o have been described, 2 although such a channel has not been reported in freshly isolated cells. 1 
Materials and Methods
RASMCs were enzymatically dissociated from thoracic aorta of male Sprague-Dawley rats. 11 Cells were superfused (0.5 mL/min) with HBSS containing, in mmol/L, NaCl 136. ] (1 to 300 nmol/L) were prepared by adding specified volumes of CaCl 2 (CaBuf software) to the 10 mmol/L EGTA pipette solution. RASMCs were continuously superfused with bath solution or drugs applied by pressure ejection from a multibarreled micropipette placed 500 m from the cell.
Membrane potential and whole-cell currents were recorded under current or voltage clamp in the whole-cell configuration of the patch-clamp technique. Unless stated, all recordings were made at least 5 minutes after gaining cell access. Currents were recorded using either 100-ms depolarizing voltage steps of 10-mV increments (every 10 seconds) from Ϫ90 to ϩ40 mV elicited from a holding potential of Ϫ80 mV or voltage ramps from Ϫ100 to ϩ40 mV at a rate of 0.0875 V/s in cells held at Ϫ60 mV. The difference current was acquired by digital subtraction of the current trace obtained at the maximal effect of a given manipulation from its corresponding control.
Cyclosporin A, FK-506, and calcineurin autoinhibitory peptide were obtained from Affiniti-Research Products. All data are expressed as meanϮSEM from n cells. Statistical difference between groups was calculated using either paired or Student's unpaired t test. For multiple comparisons, a 1-or 2-way ANOVA with Bonferroni or Student-Newman-Keuls correction methods were used. A value of PϽ0.05 was considered statistically significant.
An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org.
Results
Effects of ATP, Glibenclamide, and Levcromakalim on Whole-Cell K ؉ Currents
Under control recording conditions, RASMCs superfused with HBSS and dialyzed with 1 mmol/L EGTA and 3 mmol/L ATP had a mean capacitance of 12.1Ϯ0.6 pF (nϭ36). The average resting potential at 0.5 to 1 minute after the establishment of whole-cell recording was Ϫ38.5Ϯ2.5 mV (nϭ40), which did not significantly change after 5 minutes (Table 1) . In voltage clamp, a small instantaneous, time-independent background current was observed at negative potentials ( Figure 1A ). Superfusion with glibenclamide (10 mol/L), an inhibitor of K ATP channels, depressed this current (Figure 1 online, available at http://www.circresaha.org, and Figure 1B ) and caused a small (9 mV) but significant depolarization of the membrane ( Figure 3C ). The effects of glibenclamide were fully reversible after several minutes of washout. In addition, the K ATP channel opener levcromakalim (30 mol/L) caused a small increase in current at all potentials ( Figure 1B) 1D ). Indeed, the magnitude of the glibenclamide-sensitive current (I Glib ) and levcromakalimsensitive current (I Lev ) ( Figure 1E ) were 2.5-to 3-fold larger in 0.1 compared with 3 mmol/L [ATP] i . For example, at ϩ10 mV, I Glib increased from 33.8Ϯ6.1 pA (nϭ11) to 90.5Ϯ19.8 pA (nϭ5). Consistent with effects on K ϩ currents, the reversal potential of I Glib and I Lev was Ϫ77.6Ϯ1.2 mV (nϭ5) and Ϫ77.1Ϯ1 mV (nϭ6), respectively ( Figure 1D ), which is close to the predicted potassium equilibrium potential (E K ) under our recording conditions of Ϫ80.4 mV.
Modulation of Whole-Cell K
؉ Current by Ca
2؉
To assess the effects of Ca 2ϩ on whole-cell K ϩ current and membrane potential, 2 sets of experiments were performed. Firstly, [ ] o , the magnitude of instantaneous background current was significantly increased at all potentials ( Figure 2A ) when compared with control conditions ( Figure 1A ). This was associated with a 20 mV membrane hyperpolarization (PϽ0.001, Table 1 ). Moreover, the resting potential remained stable, measuring Ϫ59.1Ϯ3.5 mV (nϭ8) and Ϫ55.1Ϯ3.2 mV (nϭ6) after 15 and 40 minutes of recording, respectively. Superfusion of glibenclamide (10 mol/L) caused a complete inhibition of the increase in background current ( Figure 2A ) and reversed membrane hyperpolarization ( Figure 3C ). Furthermore, glibenclamide had no effect on time-dependent currents, which were apparent at positive potentials ( Figure 2A (Table  1 ). In addition, the background current was highly sensitive to block by glibenclamide (PϽ0.001, Figures 2B and 3B) , with 3 mol/L inhibiting the instantaneous current measured from the I-V at 0 mV by 80% from 99.6Ϯ24.2 pA to 21.9Ϯ2.6 pA (nϭ10). This was associated with significant membrane depolarization ( Figure 3C) .
When comparing the mean instantaneous I-V relationships for the 3 different Ca 2ϩ conditions ( Figure 3A) Figure 3B ). For example, at 0 mV, the ] i , the I-V relationship was substantially altered, with little current being activated at negative potentials. At positive potentials, current activated steeply and was noisy in appearance, being several hundred pA in size at ϩ40 mV. This current was largely unaffected by glibenclamide ( Figure 4B ), I Glib being only 16.6Ϯ3.9 pA (nϭ8) at ϩ10 mV, but it was almost completely inhibited by 300 nmol/L paxilline ( Figure 4B ), a potent inhibitor of the large-conductance Ca 2ϩ -activated K ϩ (BK Ca ) channel. 13 In contrast, paxilline had only a small effect on currents recorded in 1 nmol/L [Ca 2ϩ ] i ( Figure 4A ) or 0 [Ca 2ϩ ] o (see Figure 2 online), nor did it affect resting membrane potential in low [Ca 2ϩ ] o (Ͻ300 nmol/L; see Figure 2 online). These latter results suggest that BK Ca channels do not contribute to the resting potential, as has been observed in many smooth muscle types. 14, 15 The averaged voltage-ramp data for I Glib under the different Ca 2ϩ conditions is shown in Figure 4C , where current has been normalized to cell size. Analysis reveals that the magnitude of I Glib is negatively correlated to the free [Ca 2ϩ ] i ( Figure 4D ), whereas the magnitude of the paxilline-sensitive current (I Pax ) was enhanced by increasing (Tables 1 and 2) , as were the effects of glibenclamide on membrane potential (Table 2 and Figure 3C ). At 100 nmol/L [Ca 2ϩ ] i , cells still had a resting potential of Ϫ57 mV, although they became substantially more depolarized (Ϫ32 mV) at 300 nmol/L, where glibenclamide did not produce any significant depolarization ( 17 an enzyme known to be present in RASMCs. 18 These results suggest that a dephosphorylating event causes Ca 2ϩ channel inactivation to occur. Applying the same principle to our study, we postulated that under conditions where the [Ca 2ϩ ] i is low, the activity of PP-2B would be concomitantly re- ] o , where there was usually little background current, dialysis of RASMCs with cyclosporin A (10 mol/L), an inhibitor of PP-2B, 19 caused an increase of an instantaneous background current ( Figure 5A ), which was similar to that observed in the low [Ca 2ϩ ] conditions ( Figure 2 ). This increase was associated with significant membrane hyperpolarization from Ϫ42.0Ϯ2.7 mV at Ϸ30 seconds after gaining cell access to Ϫ58.6Ϯ1.6 mV after 5 minutes (nϭ9; PϽ0.001). This effect could be reversibly inhibited by glibenclamide (10 mol/L) ( Figure 6A ). Furthermore, cyclosporin A induced an Ϸ3-fold increase in I Glib over control conditions ( Figure 6B ). To confirm the specificity of cyclosporin A on PP-2B, we also investigated the effects of 2 structurally unrelated PP-2B inhibitors, FK-506 20 and the highly selective inhibitor calcineurin autoinhibitory peptide (CAP). 21 In 4 of 8 cells, dialysis with FK-506 (5 to 10 mol/L) for at least 5 minutes was associated with increased background currents ( Figure 5B ) and a significant hyperpolarization of the resting membrane potential (Ϫ57.6Ϯ5.9 mV, nϭ4). Again, this hyperpolarization was inhibited by glibenclamide ( Figure 6A) , and the magnitude of I Glib was large ( Figure 6B ). With FK-506, the experiments were performed in the presence of paxilline (250 nmol/L), because we observed significant activation of BK Ca current with this agent. Dialysis with CAP (10 mol/L), like cyclosporin A, resulted in every cell tested becoming significantly hyperpolarized with time. The resting potential of cells was Ϫ31.8Ϯ 2.5 mV immediately on gaining cell access and hyperpolarized to Ϫ62.3Ϯ1.3 mV after 10 minutes (nϭ18; PϽ0.001), remaining stable for several minutes thereafter. This is in contrast to control cells, where the resting potential remained close to Ϫ40 mV during the first 5 minutes of recording (see above) and declined subsequently in a number of cells. Not only did glibenclamide cause substantial depolarization (33 mV) with CAP ( Figure 6A ), but we tended to record the largest basal K ATP currents in this condition ( Figure 5C ).
Discussion
It is widely assumed that smooth muscle K ATP channels are largely insensitive to Ca 2ϩ , and so most studies to date have been carried out in low Ca 2ϩ . 1 However, we now provide direct evidence that basal K ATP current can be regulated by Ca 2ϩ in the nanomolar range in isolated smooth muscle cells. In a normal Ca 2ϩ and K ϩ gradient and in the presence of a physiological concentration of intracellular ATP (3 mmol/L), the K ATP channel inhibitor glibenclamide had a small but significant effect on membrane potential and current, suggesting that K ATP channels do indeed contribute to the resting potential in rat aorta as previously reported. 6, 7 However, increasing [EGTA] i or decreasing [Ca 2ϩ ] o increased a glibenclamide-sensitive background current by 2-to 4-fold and caused a large membrane hyperpolarization, effects similar to those observed in cells dialyzed with 1 to 10 nmol/L free [Ca 2ϩ ] i . Large K ATP currents and hyperpolarized resting potentials could also be obtained in control cells dialyzed with specific inhibitors of PP-2B (cyclosporin A, FK-506, and CAP). Thus, our results demonstrate for the first time that smooth muscle K ATP channels can be inhibited by Ca 2ϩ under basal conditions through an action that is likely to be mediated by PP-2B.
The background current was identified as being carried by K ATP channels on the basis of the following criteria. First, it was inhibited by glibenclamide in the low micromolar range, and I Glib reversed within 5 mV of the predicted E K under our recording conditions. It was essentially unaffected by paxilline, suggesting that the background current was not carried by BK Ca channels. Second, the background current was sensitive to changes in [ATP] i and increased in magnitude when [ATP] i was lowered from 3 to 0.1 mmol/L. Third, the size of the levcromakalim-sensitive background current was larger when ATP was reduced in the pipette. These are very similar pharmacological characteristics to K ATP current recorded in isolated cells from many smooth muscle types. 1 However, at this stage the molecular identity of the K ATP channel subtype modulated by Ca 2ϩ in rat aorta is unclear. Whether the whole-cell current is carried by glibenclamidesensitive, nucleotide diphosphate K ϩ channels 22, 23 or the more classical type of K ATP channel 1, 23, 24 remains to be determined.
To our knowledge, the few studies that have assessed the Ca 2ϩ sensitivity of K ATP channels in excised patches or lipid bilayers have either reported no effect [25] [26] [27] over the [Ca 2ϩ ] range of 10 to 1000 nmol/L or an increase in activity above this concentration. 2, 10, 26 In cultured porcine coronary myocytes, the sensitivity of channels to [ATP] i was reported to decrease when [Ca 2ϩ ] o was raised from 1 to 100 mol/L. 2 Our experimental observations are clearly different from all previous studies, because we report regulation in the opposite direction. Our findings are analogous to the situation in cardiac and skeletal myocytes, where K ATP channels have a high activity when excised into Ca 2ϩ -free solutions but can be inhibited when Ca 2ϩ is applied to the internal surface of the channel. 28, 29 However, the Ca 2ϩ concentrations required to inhibit the channel are much higher (Ͼ10 mol/L) than we estimate for our internal solutions. Although it is clearly difficult to predict the subsarcolemmal [ modulation or sensitivity of K ATP channels can be observed in isolated patches. This is likely to be extremely difficult to assess because of the rapid run down and low density of K ATP channels in smooth muscle. 1 Moreover, channel regulation may well be different in excised patches because of the absence of the intracellular matrix and cytosolic regulatory proteins. Thus, our results suggest that the level of Ca 2ϩ buffering should be considered when studying K ATP channels. Indeed, the differences in the ATP sensitivity of smooth muscle K ATP channels that is observed experimentally 1 may well be related to different starting levels of Ca 2ϩ . Evidence suggests that the activity of vascular K ATP channels is governed by the degree and the site of phosphorylation and dephosphorylation. 1, 14 Clearly, [Ca 2ϩ ] i level plays an important role in regulating the activity of many Ca 2ϩ -dependent or -activated proteins in the cells, such as Ca 2ϩ -dependent protein kinase C (PKC) isoforms, Ca 2ϩ / calmodulin-dependent protein kinase II, and PP-2B. 16, 19 In smooth muscle cells, K ATP channels can be opened by vasodilators stimulating protein kinase A (PKA) and closed by vasoconstrictors stimulating PKC. 1, 14 However, the effects of protein phosphatases on the modulation of K ATP channel activity in smooth muscle by PKA and PKC is far from clear. In gallbladder smooth muscle cells, PKA-mediated activation of K ATP by calcitonin gene-related peptide was shown to persist after treatment with okadaic acid (an inhibitor of Ca 2ϩ -independent PP-1 and PP-2A), suggesting that PP-1 and PP-2A dephosphorylate a PKA phosphorylation site. 3 Similarly, okadaic acid was shown to prevent cardiac K ATP channel rundown 30 and preserve PKC-induced K ATP activation. 31 Because these effects could be reversed by purified PP-2A, these studies suggested that PP-2A is responsible for dephosphorylating a PKC phosphorylation site. So far, the specific contribution of PP-2B to smooth muscle K ATP channel regulation has not been investigated, although PP-2B protein or activity has been described in many cell types, 19 suggesting that this enzyme may have important functional roles.
In this study we demonstrated that PP-2B is likely to be involved in the modulation of K ATP channels by Ca 2ϩ . Dialysis with the highly selective PP-2B inhibitor, CAP, which has an IC 50 of Ϸ5 mol/L against PP-2B, 21 activated a large glibenclamide-sensitive current and significantly hyperpolarized the resting potential in control cells. This synthetic peptide is derived from a unique sequence in the autoinhibitory domain of calcineurin and has been reported to have a high degree of specificity for this enzyme, having no significant inhibitory effect on PP-1 or PP-2A or Ca 2ϩ /calmodulindependent protein kinase II. 32 The specificity of this agent was additionally tested using 2 other structurally unrelated PP-2B inhibitors, cyclosporin A and FK-506, which inhibit the enzyme by first forming a complex with either cyclophilin A or FKBP12, respectively. 20 Both these inhibitors had effects similar to CAP, increasing whole-cell K ATP current. However, we found that FK-506, and to a much lesser extent cyclosporin A, increased BK Ca current, consistent with the known ability of FK-506 to increase [Ca 2ϩ ] i in bladder or A7r5 cells either by inhibiting the sarcoplasmic reticulum Ca 2ϩ ATPase or increasing Ca 2ϩ release from the ryanodine receptor. 33, 34 The effects of the PP-2B inhibitors on the K ATP current and membrane potential that we observed were mimicked by recording current in low [Ca 2ϩ ] i (1 to 10 nmol/L). At this concentration, the activity of this enzyme should be negligible. 19 Half-maximal activation of PP-2B by Ca 2ϩ in the presence of calmodulin occurs at Ϸ300 to 500 nmol/L, 20 which is consistent with our observation that marked inhibition of the K ATP current occurred on increasing [Ca 2ϩ ] i from 100 to 300 nmol/L. However, the regulation of PP-2B is complex, and several accessory proteins and kinases are known to modulate its activity, including PKC, 19 so that the Ca 2ϩ sensitivity in the intact cell may vary considerably between different cell types, possibly giving rise to variable basal K ATP channel activity. The mechanism by which PP-2B would regulate K ATP remains undetermined. Presumably, PP-2B regulates the degree of phosphorylation of an activation site on either the channel or a regulatory binding protein required for K ATP channel opening, possibly one targeted by PKA. The situation seems different in cardiac cells, where the broad-spectrum protein phosphatase inhibitor, fluoride, had no effect on the Ca 2ϩ -induced inhibition of K ATP channels in excised patches. 28 Moreover, in renal tubule cells, neither Ca 2ϩ nor PP-2B affected rundown of K ATP channel activity, whereas PP-2A accelerated this process. 35 This may suggest either a different K ATP channel type or different channel regulation in smooth muscle. Although no clear role for PP-2B in regulating K ATP channel in other tissues has been reported, PP-2B does seem to mediate Ca 2ϩ -induced inhibition of L-type Ca 2ϩ channels in umbilical vein smooth muscle. 17 In conclusion, we have demonstrated in rat aortic smooth muscle cells that Ca 2ϩ is an important regulator of basal K ATP channel activity within the physiological [Ca 2ϩ ] i range and provide evidence that this is mediated via PP-2B. Whether such regulation is specific to vascular smooth muscle remains to be determined. Our data strongly suggest that such a pathway may contribute to the action of vasodilator and vasoconstrictor agents on K ATP channels either through kinase or Ca 2ϩ regulation of PP-2B or from the ability of these agents to alter [Ca 2ϩ ] i levels directly.
